MET

NYSE · Insurance

Metlife Inc

Q: Who are MetLife's main competitors?

Prudential Financial is MetLife's closest peer, competing across group insurance, individual life, and retirement products in both domestic and international markets. Principal Financial Group competes in group benefits and retirement services. Lincoln National competes in group life, disability, and annuities. Aflac is a competitor in supplemental insurance sold at the workplace. In the pension risk transfer market, Prudential, Legal & General America, and Pacific Life compete for large-scale transactions from corporate pension plan sponsors.

Q: What is MET's stock price today?

MET last closed at $102.65, up 0.77% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $67.33 and a high of $106.72. The current price represents 90% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What do Wall Street analysts say about MET?

Among 24 analysts covering MET, the consensus rating is Strong Buy — 18 rate it a buy, 6 hold, and 0 sell. The average price target sits at $216.38, implying 111% upside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: Is Metlife Inc profitable?

Metlife Inc generated $71.35B in revenue during fiscal year 2026, with $3.13B reaching the bottom line as net income. The net profit margin of 4.4% reflects the competitive nature of its industry.

Q: What is MET's P/E ratio?

MET trades at a P/E ratio of 12.49 on trailing earnings of $7.91 per share. That's below the S&P 500 average, suggesting the market may see limited growth or is pricing in sector-specific risks. Comparing this multiple against Insurance sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Q: How has MET stock performed recently?

MET has been on a strong uptrend over the past year and continues to show momentum. Returns by timeframe: +0.00% (1D), +0.96% (1W), +2.37% (1M), +6.18% (3M), +26.09% (6M), +30.53% (1Y), +27.80% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether MET is outperforming or lagging the broader market.

S&P 500 Large-Cap Stocks Blue Chip Stocks Best Dividend Stocks Highest Dividend Yield

$102.65

+0.78 (+0.77%)

As of Nov 14, 1:05 AM ET ·

Day Range $101.52 — $103.46

52W Range $67.33 — $106.72

Performance

1D +0.00%

1W +0.96%

1M +2.37%

3M +6.18%

6M +26.09%

1Y +30.53%

YTD +27.80%

Open$102.83

Previous Close$101.87

Day High$103.46

Day Low$101.52

52W High$106.72

52W Low$67.33

Volume—

Avg Volume3.36M

Market Cap64.05B

P/E Ratio12.49

EPS$7.91

SectorInsurance

Technical Indicators

Full analysis →

SMA 50 $98.74 Above

SMA 200 $86.92 Above

RSI (14) 57.7 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

24 analysts

18 Buy 6 Hold 0 Sell

Price Target +110.8% upside

Current
$102.65

Target
$216.38

$147.72 $216.38 avg $328.18

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	71.35B	68.75B	56.93B
Net Income	3.13B	2.72B	4.31B
Profit Margin	4.4%	4.2%	7.6%
EBITDA	5.92B	5.42B	6.27B
Free Cash Flow	—	—	4.53B
Rev Growth	+3.8%	+3.8%	+20.2%
Debt/Equity	0.67	0.67	0.28

Dividend

Dividend Yield3.27%

Annual Dividend$2.53

Payout Ratio50.4%

Frequencyquarterly

Ex-DividendApr 10, 2026

Pay DateApr 22, 2026

About Metlife Inc

MetLife, Inc. is one of the world's largest insurance and financial services companies, headquartered in New York, New York, providing life insurance, annuities, employee benefits, and asset management products to individuals, small businesses, and large corporations. The company operates in more than 40 countries and serves hundreds of millions of customers and pension participants through its United States and International segments. MetLife is one of the leading providers of group benefits in the United States, offering dental, vision, disability, and life insurance through employers. Its global presence spans the Americas, Asia, Europe, the Middle East, and Africa.

Insurance Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
CB	Chubb Ltd	$375.74	+1.07%	12.8	143.35B
PGR	Progressive Corp	$235.78	+0.12%	11.8	136.60B
MRSH	Marsh & Mclennan Cos	$207.78	+1.02%	24.7	99.60B
MFC	Manulife Financial Corp	$44.06	+0.32%	16.1	103.50B
AON	Aon Plc-Class A	$338.31	+1.47%	18.4	72.17B
TRV	Travelers Cos Inc/The	$403.23	+0.01%	10.0	83.11B

MET Frequently Asked Questions

What does MetLife do?

MetLife sells life insurance, annuities, and employee benefits to individuals and corporations across the United States and a large international footprint spanning Latin America, Asia, Europe, and the Middle East. The company's Group Benefits segment sells life, disability, dental, and vision products to employers as workplace benefits. Its Retirement Income Solutions segment sells annuities and pension risk transfer products, where MetLife takes on retirement obligations from corporations seeking to offload pension liabilities — a growing market as defined-benefit plans mature.

Is MET stock a good investment?

MetLife's investment portfolio — the asset base backing its insurance liabilities — benefits when interest rates rise, as reinvested premiums earn higher returns and new annuity products become more attractive. The company has simplified its portfolio, divesting its U.S. retail life insurance arm (now Brighthouse Financial) to focus on higher-return institutional and group businesses. Book value per share growth and return on equity are the primary metrics MetLife management emphasizes. The international segment introduces emerging market currency and regulatory risk alongside growth potential.

Who are MetLife's main competitors?

Prudential Financial is MetLife's closest peer, competing across group insurance, individual life, and retirement products in both domestic and international markets. Principal Financial Group competes in group benefits and retirement services. Lincoln National competes in group life, disability, and annuities. Aflac is a competitor in supplemental insurance sold at the workplace. In the pension risk transfer market, Prudential, Legal & General America, and Pacific Life compete for large-scale transactions from corporate pension plan sponsors.

Does MetLife pay dividends?

MetLife has paid a quarterly dividend for many years and increases it gradually in line with earnings growth. The yield is one of the higher ones in the life insurance sector, reflecting a balance between returning capital to shareholders and maintaining the surplus levels that regulators and rating agencies expect insurers to hold. Management supplements the dividend with share repurchases, authorized annually and executed opportunistically depending on market conditions and capital levels. The dividend is viewed as stable barring a significant deterioration in investment portfolio performance.

What is MET's stock price today?

MET last closed at $102.65, up 0.77% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $67.33 and a high of $106.72. The current price represents 90% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What do Wall Street analysts say about MET?

Among 24 analysts covering MET, the consensus rating is Strong Buy — 18 rate it a buy, 6 hold, and 0 sell. The average price target sits at $216.38, implying 111% upside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Is Metlife Inc profitable?

Metlife Inc generated $71.35B in revenue during fiscal year 2026, with $3.13B reaching the bottom line as net income. The net profit margin of 4.4% reflects the competitive nature of its industry.

What is MET's P/E ratio?

MET trades at a P/E ratio of 12.49 on trailing earnings of $7.91 per share. That's below the S&P 500 average, suggesting the market may see limited growth or is pricing in sector-specific risks. Comparing this multiple against Insurance sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

How has MET stock performed recently?

MET has been on a strong uptrend over the past year and continues to show momentum. Returns by timeframe: +0.00% (1D), +0.96% (1W), +2.37% (1M), +6.18% (3M), +26.09% (6M), +30.53% (1Y), +27.80% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether MET is outperforming or lagging the broader market.